Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001415889-24-021364 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-15 | 2024-08-13 | SPRY | Dorsey Brian | COO | S - Sale+OE | $13.00 | -30.0K | 6,024 | -83% | -$390.0K |
| D | 2024-08-15 | 2024-08-13 | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +30.0K | 36.0K | +498% | +$19.2K |
| D | 2024-08-15 | 2024-08-13 | SPRY | Dorsey Brian | COO | M - OptEx | $0.00 | -30.0K | 111.8K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-13 | S | D | 30,000 | $13.00 | 6,024 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-13 | M | A | 30,000 | $0.64 | 36,024 | D | — | — | (F1) Includes 2,159 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") on June 30, 2023, 1,013 shares acquired under the ESPP on December 29, 2023 and 2,852 shares acquired under the ESPP on June 29, 2024. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-13 | M | D | 30,000 | $0.00 | 111,828 | D | $0.64 · — to 2028-11-28 | 30,000 Common Stock | (F3) Immediately exercisable. |